QT
PACB icon

Quantbot Technologies’s Pacific Biosciences PACB Stock Holding History

Quantbot Technologies’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1K Buy
11,949
+11,948
+1,194,800% +$17.4K ﹤0.01% 1781
2026
Q1 		$1 Buy
+1
New +$2 ﹤0.01% 1647
2024
Q2 		– Sell
-88,834
Closed -$333K – 1794
2024
Q1 		$333K Buy
88,834
+68,195
+330% +$399K 0.02% 863
2023
Q4 		$202K Sell
20,639
-99,174
-83% -$811K 0.01% 1017
2023
Q3 		$1M Sell
119,813
-43,211
-27% -$494K 0.07% 415
2023
Q2 		$2.17M Buy
+163,024
New +$1.98M 0.14% 211
2022
Q3 		– Sell
-151,259
Closed -$668K – 1958
2022
Q2 		$668K Buy
151,259
+115,466
+323% +$702K 0.06% 476
2022
Q1 		$325K Buy
35,793
+33,415
+1,405% +$385K 0.03% 721
2021
Q4 		$48K Sell
2,378
-59,032
-96% -$1.42M ﹤0.01% 1038
2021
Q3 		$1.57M Buy
61,410
+20,447
+50% +$606K 0.11% 250
2021
Q2 		$1.43M Buy
+40,963
New +$1.19M 0.11% 260
2018
Q4 		– Sell
-2,200
Closed -$11K – 1302
2018
Q3 		$11K Buy
+2,200
New +$9.44K ﹤0.01% 1165
2018
Q1 		– Sell
-100
Closed – – 1436
2017
Q4 		$0 Buy
+100
New +$350 ﹤0.01% 1401
2016
Q2 		– Sell
-6,211
Closed -$52K – 1277
2016
Q1 		$52K Buy
+6,211
New +$61.1K 0.01% 862
2015
Q3 		– Sell
-260
Closed -$1K – 1356
2015
Q2 		$1K Buy
+260
New +$1.5K ﹤0.01% 1066
2015
Q1 		– Sell
-4,097
Closed -$32K – 1277
2014
Q4 		$32K Sell
4,097
-3,350
-45% -$21.4K 0.01% 895
2014
Q3 		$36K Buy
+7,447
New +$38.9K 0.01% 1004
2014
Q2 		– Sell
-400
Closed -$2K – 1326
2014
Q1 		$2K Buy
+400
New +$2.53K ﹤0.01% 1059

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Quantbot Technologies's PACB Position: Q2 2026 in Review

Quantbot Technologies increased its Pacific Biosciences (PACB) stake by 1,194,800% in Q2 2026, buying an estimated $17.4K and bringing the position to 11,949 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Quantbot Technologies first reported a position in PACB in Q1 2014 and has held it in 18 quarters since. The position peaked at $2.17M in Q2 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Quantbot Technologies held 11,949 shares of Pacific Biosciences worth $20.1K as of Q2 2026.
  • Quantbot Technologies bought 11,948 Pacific Biosciences shares in Q2 2026, an estimated $17.4K.
  • Pacific Biosciences made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1781 holding.
  • Quantbot Technologies first reported a position in Pacific Biosciences in Q1 2014 and has held it in 18 quarters since.
  • Quantbot Technologies's Pacific Biosciences position peaked at $2.17M in Q2 2023.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.